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Human Cytomegalovirus (HCMV) is a highly prevalent herpesvirus, persistently infecting
between 30 and 100% of the population, depending on socio-economic status (Fields
et al., 2013). HCMV remains an important clinical pathogen accounting for more than
60% of complications associated with solid organ transplant patients (Kotton, 2013;
Kowalsky et al., 2013; Bruminhent and Razonable, 2014). It is also the leading cause
of infectious congenital birth defects and has been linked to chronic inflammation and
immune aging (Ballard et al., 1979; Griffith et al., 2016; Jergovic et al., 2019). There is
currently no effective vaccine and HCMV antivirals have significant side effects. As current
antivirals target viral genes, the virus can develop resistance, reducing drug efficacy.
There is therefore an urgent need for new antiviral agents that are effective against HCMV,
have better toxicity profiles and are less vulnerable to the emergence of resistant strains.
Targeting of host factors that are critical to virus replication is a potential strategy for
the development of novel antivirals that circumvent the development of viral resistance.
Systematic high throughput approaches provide powerful methods for the identification
of novel host-virus interactions. As well as contributing to our basic understanding of
virus and cell biology, such studies provide potential targets for the development of novel
antiviral agents. High-throughput studies, such as RNA sequencing, proteomics, and
RNA interference screens, are useful tools to identify HCMV-induced global changes in
host mRNA and protein expression levels and host factors important for virus replication.
Here, we summarize new findings on HCMV lytic infection from high-throughput studies
since 2014 and how screening approaches have evolved.
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INTRODUCTION
Human cytomegalovirus (HCMV) is a ubiquitous human pathogen that belongs to the
β-herpesvirus subfamily. It has the largest DNA genome among the human herpesviruses with
∼235 kb pairs, and encodes at least 173 annotated genes based on the low-passage strain
Merlin, the current reference strain for wild-type HCMV (Dunn et al., 2003; Fields et al., 2007;
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Sijmons et al., 2014; Marti-Carreras and Maes, 2019). HCMV
can infect a broad range of cell types, including endothelial
and epithelial cells, fibroblast cells and cells derived from the
myeloid lineages (Rice et al., 1984; Sinzger et al., 2008). It has
a relatively long lytic replication cycle which can take up to
72 h to start releasing infectious virions into the extracellular
compartment (Landolfo et al., 2003). A lifelong latent infection
can be established in primitive bone-marrow-resident CD34+
hematopoietic stem cells and CD33+ myeloid progenitor cells
which retain the latent viral genome as they differentiate into
peripheral blood CD14+ monocytes and myeloid dendritic cells
(mDCs) (Collins-McMillen et al., 2018; Arcangeletti et al., 2016;
Stern et al., 2019). Reactivation of the latent viral genome occurs
Abbreviations: 3′UTR, 3′ untranslated regions; AGO2, Argonaute 2; AGO-
CLIP-seq, Argonaute-crosslinking and immunoprecipitation sequencing; AMPK,
5′ AMP-activated protein kinase; ANAPC1, Anaphase-promoting complex
subunit 1; ANKRD52, Ankyrin repeat domain 52; APA, Alternative cleavage
and polyadenylation; ARPE-19, Adult retinal pigment epithelial cell line 19;
AS, Alternative splicing; ASNS, Asparagine synthetase; ATP6V0C, ATPase
H+ transporting V0 Subunit C; BRD2, Bromodomain-containing protein
2; CD4, Cluster of differentiation 4; CDK6, Cyclin dependent kinase 6;
CFL2, Cofilin 2; CHEK1, Checkpoint kinase 1; CLIP-seq, Cross-linking
immunoprecipitation-sequencing; COPA, Coatomer protein complex subunit
alpha; COPB2, Coatomer protein complex subunit beta 2; CPEB1, Cytoplasmic
polyadenylation element binding protein 1; CRISPR, Clustered regularly
interspaced short palindromic repeats; crRNA, CRISPR RNA; CUL4, Cullin 4;
CXCL2, Chemokine (C-X-C motif) ligand 2; DKK1, Dickkopf WNT signaling
pathway inhibitor 1; DPI, Days post-infection; DSB, Double-strand break; ECs,
Endothelial cells; eGFP, Enhanced green fluorescent protein; ERAD, Endoplasmic
reticulum associated protein degradation; ERC1, ELKS/RAB6-interacting/CAST
family member 1; ERK/MAPK, Extracellular signal-regulated kinase/mitogen-
activated protein kinase; EXOSC10, Exosome component 10; FACS, Fluorescent
activated cell sorting; GeCKO, Genome-wide CRISPR knockout; HCMV, Human
cytomegalovirus; HDR, Homology directed repair; HEL, Human embryonic
lung fibroblast cells; HFFs, Human foreskin fibroblast cells; HLTF, Helicase-like
transcription factor; HPI, Hours post-infection; HSV-1, Herpes simplex virus 1;
HTVs, Human targets of the viral miRNAs; IFN-, Interferon-; IL-, Interleukin-
; IRF1, Interferon regulatory factor 1; IRF2BPL, Interferon regulatory factor
2 binding protein like; IRF9, Interferon regulatory factor 9; ISGs, Interferon
stimulated genes; Jak1, Janus kinase 1; kb, Kilobases; mDCs, Myeloid dendritic
cells; MELK, Maternal embryonic leucine zipper kinase; miRNA, MicroRNA;
mRNA, Messenger RNA; mTOR, Mammalian target of rapamycin; MYO18A,
Myosin XVIIIA; NEDD4, Neural precursor cell expressed, developmentally
downregulated protein 4; NGS, Next generation sequencing; NHDF, Normal
human dermal fibroblast cells; NHEJ, Non-homologous end-joining; NPCs,
Neural progenitor cells; OR14I1, Olfactory receptor family 14 subfamily I member
1; PDGFRα, Platelet-derived growth factor receptor alpha; PHLDA1, Pleckstrin
homology like domain family A member 1; PI3K-C2A, Phosphatidylinositol
3-kinase, Class 2, Alpha; PI4K2B, Phosphatidylinositol 4-kinase type 2-beta;
PIK3C3, Phosphatidylinositol 3-kinase catalytic subunit type 3; pri-miRNA,
Primary miRNA; pSILAC, Pulsed stable isotope labeling with amino acids in
cell culture; PSMC2, Proteasome 26S subunit, ATPase 2; PSMD1, Proteasome
26S subunit, non-ATPase 1; RAB4B, Ras-related GTP-binding protein 4B; RISC,
RNA-induced silencing complex; RISC-IP, RNA-induced silencing complex-
immunoprecipitation; RNAi, RNA interference; RNA-seq, RNA-sequencing;
rRNA, Ribosomal RNA; RT-qPCR, Reverse transcription-quantitative polymerase
chain reaction; sgRNA, Single-guide RNA; shRNA, Short hairpin RNA; siRNA,
Small interfering RNA; STAT2, Signal transducer and activator of transcription 2;
TGFBR1, Transforming growth factor beta receptor 1; TLRs, Toll-like receptors;
TMEM129, Transmembrane protein 129; TMT, Tandem mass tags; TSC2,
Tuberous sclerosis subunit complex 2; TXNIP, Thioredoxin interacting protein;
UAE1, Ubiquitin-activating enzyme E1; UBE2J2, Ubiquitin conjugating enzyme
E2 J2; VAC, Virion assembly compartment; VCP, Valosin containing protein;
WNK4, WNK lysine deficient protein kinase 4.
when latently infected cells reach terminal differentiation to
mDCs andmacrophages, accompanied by chromatin remodeling
of the HCMV major immediate-early promoter (Reeves et al.,
2005). Other factors such as allogeneic stimulation and pro-
inflammatory cytokines such as interferon gamma (IFN-γ) have
also been implicated in driving the maturation of myeloid cells
and reactivation of latently infected cells (Stern et al., 2019).
Viruses are obligate intracellular pathogens which rely on host
cell machinery to infiltrate, replicate in, and egress target cells.
HCMV has complex interactions with various host factors, and
host-virus interactions vary among permissive cell types as well as
between lytic and latent stages of virus infection. Characterizing
changes in host RNA expression and proteomes upon infection
can help dissect these complex host-virus interactions, as the
virus is likely to induce host factors required for efficient virus
replication and to suppress factors that would otherwise inhibit
virus replication. Studying how the virus interacts with the host
can contribute to a better understanding of virus biology as well
as functions of host factors. Furthermore, host factors that are
identified as critical for virus replication can be targeted by small
molecule inhibitors, thereby leading to potentially novel HCMV
antiviral therapies.
High-throughput studies are powerful tools to systematically
study host-virus interactions. There are many strategies to
dissect the complex interactions between a virus and host cells.
RNA sequencing and mass spectrometry allow the temporal
and spatial expression of viral and host factors to be monitored
during the course of infection, subsequently discovering the
mechanism of viral manipulation of host machinery and the
host factors important for virus replication (Weekes et al.,
2014; Jean Beltran et al., 2016). In addition, the expression
of host genes can be systematically silenced through the
RNA-induced silencing complex (RISC) or disrupted via
clustered regularly interspaced short palindromic repeats
(CRISPR) technology (Polachek et al., 2016; McCormick
et al., 2018). The resulting effects of individual gene depletion
or disruption on virus replication can be examined using
a reporter system such as luminescence, enhanced green
fluorescence protein (eGFP), or immunofluorescence staining
for viral proteins. Finally, instead of silencing gene expression,
host genes, such as interferon stimulated genes (ISGs) can
be overexpressed using arrayed lentivirus libraries and
host restriction factors against the virus can be identified
(Schoggins et al., 2011).
Previously, a thorough review was published in 2014,
discussing how HCMV manipulates host metabolism and gene
expression using RNA sequencing (RNA-seq), proteomics
and high-throughput RNAi screens (Cohen and Stern-
Ginossar, 2014). However, studies using high throughput
or systematic approaches have made major contributions to
our understanding of HCMV biology, both in the lytic and
latent aspects, in the last 5 years. Therefore, in this review,
we summarize high-throughput studies in HCMV, focusing
on lytic infection, from 2014 to current. The review will be in
two major parts: (i) how the virus changes cellular RNA and
protein expression, and (ii) how changes to host cells impact
virus replication.
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GLOBAL ANALYSIS OF HCMV-INDUCED
CHANGES IN HOST GENE EXPRESSION
BY RNA-SEQ AND PROTEOMICS
Upon infection, HCMV induces global changes in host protein
expression to overcome host innate immune defenses and divert
normal cellular processes away from the host to the virus
to facilitate efficient virus replication. These changes may be
observed at RNA levels where viral proteins directly interact with
the host DNA or chromatin or indirectly to increase or decrease
specific host gene expression, thereby creating an environment
conducive to efficient replication and spread. However, mRNA
transcripts are subject to post-transcriptional regulation and
degradation, and the levels of transcripts and proteins do not
always correlate. Therefore, analyzing changes in protein levels
upon infection can demonstrate whether alterations in mRNA
level correspond to changes in protein levels and whether
the changes in protein expression have roles and functions in
HCMV replication.
RNA-seq Studies in HCMV
RNA-sequencing (RNA-seq) has revolutionized our ability to
monitor gene expression levels on a genome wide basis.
Techniques such as purification of poly-A transcripts or
depletion of ribosomal RNA (rRNA) have improved the
sensitivity and accuracy of RNA-seq (Zhao et al., 2018). In
addition to using RNA-seq to quantify RNA levels, novel
strategies have been developed to investigate post-transcriptional
events including alternative splicing (AS) and alternative cleavage
and polyadenylation (APA), as these events determine the coding
potentials of mRNA transcripts and regulate gene expression.
AS is a tightly regulated process that generates multiple mRNA
isoforms by using different combinations of splice sites and
exons. Several classes of splicing patterns include exon skipping,
alternative 5′ splice site selection, and retention of introns
(Movassat et al., 2016). Meanwhile, APA involves the use of
alternative poly(A) sites located in internal introns or exons to
form multiple mRNA isoforms.
Polyadenylation is a two-step process involving specific
endonucleolytic cleavage and polymerisation of the adenosine tail
of which length is host-specific and is often about 200 residues
in higher eukaryotes (Lutz and Moreira, 2011). Poly(A) tails are
found on the 3′ end of nearly every eukaryotic mRNA transcript
and a particular poly(A) site is chosen depending on the strength
of the poly(A) signal and surrounding cis-elements (Millevoi and
Vagner, 2010; Fu and Ares, 2014). APA can also occur in the
3′ untranslated regions (3′UTR) resulting in transcription with
different 3′UTR lengths, which has been suggested to affect the
stability, localization, transport and translation of the mRNA
(Movassat et al., 2016).
AS has been identified in around 95% of human genes
whilst APA in about 70% of human genes (Pan et al., 2008;
Derti et al., 2012). AS and APA can affect many cellular
processes including RNA stability, translation, miRNA targeting,
development, and disease (Lutz and Moreira, 2011). RNA-seq
was used to study how AS and APA alters the host transcriptomes
at the post-transcription level following infection with HCMV.
Batra et al. (2016) assessed mRNA expression patterns in three
HCMV-permissive cell types using splicing-sensitive Affymetrix
microarrays and poly-A selected RNA-seq. RNAs were extracted
from primary human foreskin fibroblast cells (HFFs), human
aortic endothelial cells (ECs), and human embryonic stem cell
derived neural progenitor cells (NPCs) at 48 and 96 h post-
infection (HPI) with HCMV strain TB40/E. Changes in APA
and AS resulted in over 2,000 alterations in host transcripts
following infection with HCMV. Using Mixture of isoforms
(MISO) algorithm, it was found that the majority of APA events
resulted in shortened 3′UTRs post-infection in all three cell
types tested, with 3′UTRs shorten by up to 5 kilobases (kb)
at 96 HPI. To evaluate the regulation of APA at the 3′UTR,
RNA-seq analysis revealed a drastic upregulation of cytoplasmic
polyadenylation element binding protein 1 (CPEB1) mRNA
levels, which corresponded to increased protein expression.
Depletion of CPEB1 by small interfering RNA (siRNA) during
infection partially or completely reversed 41% of APA changes
in infected HFFs, whilst overexpression of CPEB1 resulted in
a significant shift toward utilization of proximal poly(A) sites
in genes found to be affected during infection. Furthermore,
depletion of CPEB1 also shortened poly(A) tails in HCMV genes,
such as UL18 and UL99, and decreased productive HCMV
infection in HFFs, although the magnitude of decrease was
more substantial at 96 HPI (around 10-fold) and the titer
recovered partially by 144 HPI. This study demonstrates the
power of systematic approaches for understanding how viruses
can manipulate gene expression levels on a global scale.
Proteomics Studies in HCMV
mRNA levels don’t always correspond to protein levels due
to various factors, including post-transcriptional modification,
mRNA stability, and regulation by miRNAs (Valencia-Sanchez
et al., 2006; Nachtergaele and He, 2017; Nouaille et al., 2017;
Mauger et al., 2019). Therefore, measuring protein levels during
infection can provide a more direct functional relationship
between the virus and the host (Koussounadis et al., 2015; Liu
et al., 2016). A seminal and quantitative proteomic study on the
precise temporal expression of plasma membrane proteins and
intracellular proteins was conducted by Weekes et al. (2014).
Tandem mass tags (TMT) were used to quantify 1,184 cell-
surface proteins and 7,491 cellular proteins from up to 10
time points in HFFs. Several cell-surface and cellular proteins
in the interferon (IFN) signaling pathway were found to be
downregulated by HCMV strain Merlin, including Jak1, STAT2,
and IRF9. More recently, a similar strategy was adapted to
focus on host proteins with innate immune function that are
actively degraded by the proteasome or lysosome during early-
stage HCMV infection (Nightingale et al., 2018). Using the
proteasome inhibitor MG132, or leupeptin, an inhibitor against
lysosome function, HFFs were infected with Merlin strain and
analyzed at 12, 18, and 24 HPI by MS3 mass spectrometry. Eight
thousand six hundred and seventy-eight proteins were assessed
between infected cells treated with or without the proteasomal
or lysosomal inhibitor. Overall, 131 proteins, including E3
ubiquitin ligase ANAPC1 and HCMV restriction factor Sp100,
were rescued by application of MG132 within 24 HPI, with 46
proteins rescued at 12 HPI. Meanwhile, 28 proteins, including
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E3 ligase NEDD4, were rescued by application of leupeptin.
Fifty percentage of proteins rescued by leupeptin were also
rescued by MG132. To address protein stability and turnover
during HCMV infection, an unbiased pulsed stable isotope
labeling with amino acids in cell culture (pSILAC) with the
chemical tag TMT was used. In comparison to conventional
pSILAC approach, the combination of pSILAC with TMT allows
better time efficiency in mass spectrometry and higher accuracy
of protein measurement of each protein at every time point.
The multiplexed pSILAC/TMT approach involves labeling cells
with “medium” lysine (2H4 L-lysine; Lys4), providing cells with
“heavy” lysine (13C6
15N2 L-lysine; Lys8) at the time of infection
to identify newly synthesized peptides, and labeling peptides
with TMT for mass spectrometry. pSILAC results showed that
24 of 46 proteins rescued at 12 HPI with MG132 exhibited
increased degradation in HCMV-infected cells compared to
mock infection, whilst 12 proteins did not exhibit instability
or degradation. Some of these proteins had extremely high
turnover rate, making it difficult to observe a difference between
mock and HCMV infection (e.g., TXNIP), whereas some of
these proteins were also rescued by the application of MG132
during mock infection (e.g., PHLDA1). In summary, proteins
that were rescued by MG132 but did not exhibit instability
by pSILAC may still be degraded, and post-transcriptional and
post-translational regulations may have worked in combination
to regulate the gene expression. In addition, RNA-seq analysis
was performed to identify proteins for which expression was
determined primarily by post-transcriptional regulation rather
than mRNA transcription. Several candidates were shown to
have upregulated transcription but downregulation of protein
expression, including the HCMV restriction factor Sp100, an
E3 ubiquitin ligase ANAPC1 and the helicase-like transcription
factor HLTF. The authors further characterized HLTF, which
was not previously reported to be targeted for proteasomal
degradation by HCMV, and found that UL145 is necessary and
sufficient to degrade HLTF. UL145 was also found to recruit the
Cullin 4 (CUL4) E3 ligase complex to target HLTF to proteasomal
degradation. Finally, HLTF was shown to act as a restriction
factor similar to Sp100, at an early stage of virus replication.
Another proteomic study conducted by Jean Beltran et al.
(2016) investigated both temporal and spatial changes in cellular
protein expression during HCMV infection using subcellular
fractionation and TMT-based mass spectrometry. The HCMV
infection cycle was separated into five time points (24, 48, 72,
96, and 120 HPI) and six spatial fractions by density gradient
ultracentrifugation. The study revealed that nearly 4,000 host
proteins in HFFs had undergone subcellular reorganization
during HCMV infection and the lysosomes were remodeled
into two distinct subpopulations during infection. The authors
followed up on one of the hits, myosin XVIIIA (MYO18A), and
showed that MYO18A translocated from the plasma membrane
to lysosomes during infection. Knockdown of MYO18A by
siRNA also showed a modest reduction in virus replication,
measured by IE1 positive infectious units. MYO18A is involved
in actin retrograde flow at the cell lamella and vesicle trafficking.
A model was thus proposed suggesting MYO18A is translocated
from the plasma membrane to the virus assembly compartment
to tether viral loaded vesicles and motor proteins. The same
group further investigated the global changes in peroxisome
biogenesis during HCMV infection using targeted quantitative
proteomics (Jean Beltran et al., 2018). Sixty peroxisomal proteins
that were found suitable for quantification by mass spectrometry
in HFFs were analyzed at 0, 6, 24, 48, 72, and 120 HPI with
HCMV strain AD169 using high-resolution parallel reaction
monitoring assay for high resolution and high mass accuracy.
Overall, the abundance of most peroxisomal proteins (52 of
60) increased from 24 HPI. The authors subsequently showed
that the induction of peroxisomal protein expression does not
require the expression of late genes and peroxisome biogenesis
are required for efficient HCMV replication.
In addition to studies that explore the global changes of
proteomes, a study by Arend et al. focused on the changes in
activity and expression level of host kinases using a multiplexed
kinase inhibitor bead-mass spectrometry (MIB-MS) (Arend
et al., 2017). Using beads that contain immobilized pan kinase
inhibitors for kinase capture, the study identified temporal
changes in the complement of host protein kinases (i.e., the
kinome) during HCMV infection. The laboratory adapted strain
AD169 and the clinical relevant strain TB40/E were used to
infect MRC-5 fibroblast cells in order to compare the changes
in kinome induced by two different strains. Interestingly, both
AD169 and TB40/E modify host kinome in a similar manner.
The results showed that 53 kinases including cyclin-dependent
kinases (e.g., CDK1, CDK7) and lipid kinases (e.g., PIK3C3,
PI4K2B) had increased expression during infection. Meanwhile,
51 kinases, such as platelet-derived growth factor receptor alpha
and beta (PDGFRα and PDGFRβ) and transforming growth
factor beta receptor 1 and 2 (TGFBR1 and TGFBR2), had
reduced expressing following infection. The study confirmed
the importance of previously reported AMPK, mTOR and
ERK/MAPK signaling pathways during HCMV infection, as well
as identifying ephrin (Eph) receptor kinases as novel pathways
affected by HCMV. Based on the MIB-MS kinome profiling data,
the authors tested 13 kinase specific inhibitors that are currently
in clinical use or trials for their potential to inhibit HCMV
infection. An AD169 virus expressing pp28 protein fused to the
GFP on its C-terminus (pp28-GFP) was used to monitor the
level of virus infection following drug treatment. It was found
that four inhibitors significantly decreased pp28-GFP expression.
These are OTSSP167 [targeting maternal embryonic leucine
zipper kinase (MELK)], dinaciclib (targeting CDK1, 2, 5, and 9),
OTX015 (targeting bromodomain-containing proteins BRD2, 3,
and 4), and LY2603618 [targeting checkpoint kinase 1 (CHEK1)].
Detailed characterization was performed on OTSSP167 and
virus infection was shown to decrease by 1 log following drug
treatment. This study demonstrates the potential of identifying
antiviral targets using kinome profiling.
SYSTEMATIC IDENTIFICATION OF NOVEL
HOST-VIRUS INTERACTIONS USING RNA
INTERFERENCE AND CRISPR/CAS9
Global analysis of RNA and protein levels during HCMV
infection can help understand how the virus manipulates
cellular gene expression as well as how cells respond to
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infection. However, certain host factors may not have differential
expression before and after infection, but their functions are
important for efficient virus replication.With the development of
RNA interference (RNAi) using small interfering RNA (siRNA)
and short hairpin RNA (shRNA), expression of host factors
can be systematically silenced and the effect of individual gene
depletion on virus replication can be investigated. In addition,
the recently developed and advanced CRISPR genome editing
technology allows mutations to be introduced to target genes and
disrupt protein expression of host factors that are important for
virus replication.
siRNA screens are usually performed in arrayed fashion where
each well in a microplate has a unique RNAi reagent targeting
one gene. On the other hand, shRNA screens are often performed
as pooled screens where all RNAi reagents are pooled together
and introduced randomly to cells, where shRNAs can be detected
by next generation sequencing (NGS) or barcode microarray
following phenotypic selection. High-throughput RNAi screens
have contributed greatly to our understanding of basic cell
biology as well as complex host-virus interactions which can lead
to development of novel therapeutics.
siRNA Studies in HCMV
siRNAs are regulatory RNA duplexes, usually 21–23 nucleotides
long, with 2 nucleotide overhangs on the 3′ ends. They bind
to complementary mRNA transcripts, causing degradation (Rao
et al., 2009). siRNAs usually have one mRNA target, and
the guide strand of an siRNA is incorporated into the RNA-
induced silencing complex (RISC) which uses the guide sequence
to recognize a target transcript for degradation (Lam et al.,
2015). Because of its simplicity and specificity, siRNA has been
adapted in high-throughput screens to perform systematic loss-
of-function studies in order to identify genes important for
normal cellular functions or virus replication.
Important aspects to consider when attempting high
throughput virus siRNA screens is whether the chosen readout
will generate a broad dynamic range and accurately reflect virus
replication and, ultimately, virus production. The dynamic range
of a screen describes the signal to noise ratio. If the chosen
readout for virus replication generates a maximal signal of 2-fold
over background, the sensitivity of the screen will be poor as
the largest phenotype possible would be a 2-fold reduction.
In contrast, a screen that generates a 100-fold dynamic range
provides far greater scope for defining phenotypic effects and
increases the sensitivity of the screen. In addition, if the readout
does not accurately reflect virus replication and, arguably the
more critical measurement, virus production, the false discovery
rate will be substantially higher. Conventional siRNA screens
often use reporter constructs incorporated into the viral genome
to generate a signal that reflects virus replication. While this
approach allows for rapid, efficient and real-time measurement
of signal, any effects on virus replication are biased toward early
events such as entry and genome replication and may be less
effective at measuring late events such as assembly and egress.
Previously we showed that measuring viral replication based on
expression of fluorescence cassette incorporated into the virus
genome alone, was a poor predictor of effects on late aspects
of virus replication (McCormick et al., 2018). Furthermore,
basing the readout directly on a fluorescent reporter can result
in the identification of genes that have a direct effect on the
fluorescent signal rather than through inhibition or promotion
of virus replication.
Another aspect to consider is the potential for off-target
effects, where the observed phenotype is caused by inhibition
of a gene other than the intended target. The use of pooled
siRNAs has reduced problems of off-target effects. By using
three to four independent siRNAs that target different regions
of a transcript, concentrations of each siRNA can be reduced,
thereby diminishing the risk of off target effects, while generating
synergistic RNAi activity, improving efficiency and specificity of
knockdown. However, careful validation is still required for any
potential hit and pooled siRNAs can be deconvoluted during
hit validation and individual siRNAs examined to confirm the
specificity of knockdown.
In this section we describe a number of HCMV siRNA
screens that have used alternative approaches to measure virus
replication, enabling improved measurement of early and late
aspects of HCMV virus replication.
Polachek et al. (2016) performed an siRNA screen to
determine the role of cellular kinases and phosphatases on
HMCV replication. In this study, 789 human kinases and
phosphatases were targeted in HFFs using siRNA pools and
the HCMV laboratory strain AD169. The immunofluorescence
staining of viral antigen pp28 (UL99-encoded) at 72 HPI was
employed as an indication of the level of viral replication.
A high-throughput high-content confocal microscopy with an
ImageXpress Micro microscope was used to quantify the level
of pp28 expression, allowing image capturing in microplate
systems. As pp28 is a late gene, visualization of this protein
would more accurately reflect all stages of virus replication. The
results showed that 25 siRNAs had enhancing effects on HCMV
replication with Z-scores above 1 whilst 30 siRNAs had inhibitory
effects with Z-scores below −1. Z-score describes how many
standard deviations a given measurement lies above or below
a population mean (Curtis et al., 2016). Only 4 siRNA pools
targeting phosphatidylinositol 3-kinase class II alpha (PI3K-
C2A), cluster of differentiation 4 (CD4), exosome component
10 (EXOSC10) and WNK lysine deficient protein kinase 4
(WNK4) were found to have strong inhibitory effects (Z-scores
below −2) on HCMV replication. However, CD4 and WNK4
were not found to be expressed in HFFs infected with HCMV;
thus, they were excluded from further analysis. PI3K-C2A was
further characterized since it had not been previously linked to
HCMV replication at the time of the study. The PI3K family is
important for nearly all aspects of cell biology, acting at nearly
all cellular membranes to regulate a wide range of signaling,
membrane trafficking and metabolic processes (Jean and Kiger,
2014). The authors demonstrated that all 4 siRNAs from the
siRNA pool against PI3K-C2A significantly reduced the number
of pp28 positive cells; however, western blot analysis showed that
knockdown of PI3K-C2A resulted in a modest decrease of pp28.
Therefore, it was suggested that PI3K-C2A depletion is more
likely to affect the production of viral or cellular factors important
for productive replication rather than pp28 expression. Using
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electron microscopy, the authors also showed that knockdown
of PI3K-C2A leads to an accumulation of capsids that had
undergone secondary envelopment but was not released from
the cell. Interestingly, both PI3K class I and class III have been
shown to be involved in the intracellular signaling and secondary
envelopment during HCMV infection, respectively, thus, the
identification of PI3K class II as an important host factor for
HCMV replication illustrates the involvement of all three classes
of PI3K in HCMV replication and functional differences among
classes of the same protein family (Johnson et al., 2001; Sharon-
Friling and Shenk, 2014).
A virus expressing a fluorescence reporter can also be used as
an indirect indication of infection and replication. For example,
a GFP-expressing TB40/E virus (TB40/E-GFP) was developed
by inserting an SV40 promoter-driven GFP cassette into the
intragenic region between TRS1 and US34 (Umashankar et al.,
2011). The use of a GFP-expressing virus can significantly reduce
the time for the measurement of infection level, as long as the
GFP expression represents or correlates with virus replication.
Conventionally, siRNA screens were performed in one cycle of
replication, where cells were transfected with siRNA, infected
with virus and viral gene expression or viral genome copies
were measured as an indication of virus replication. However,
this approach can miss host factors that are involved in the
later stages of the virus life cycle, such as virion assembly and
egress. The approach of collecting supernatant following the first
round of replication and assaying the supernatant for infectious
virions on cells can address this issue. The aforementioned
TB40/E-GFP virus was used in a medium-throughput siRNA
screen, undertaken in our laboratory, using a library against
160 host genes involved in membrane organization (Lin et al.,
2017; McCormick et al., 2018). The readout of GFP is a direct
measure of infection but only an indirect measure of virus
production. In contrast to conventional single-step screens, a
two-step screening approach was used in this study. This involves
the collection of supernatant at the end of the primary replication
screen at 7 days post-infection (DPI), and the transfer of the
supernatant to fresh untransfected cells, to measure production
of infectious virus progeny by GFP expression. This approach
independently measures virus replication and production using
GFP readout which can be measured by plate cytometry. We
showed a striking lack of correlation between the results from
primary replication and virus production screens. For example,
knockdown of some candidates reduced the level of GFP
expression in primary replication but the level of infectious
virus progeny was unaffected. Some of these factors may be
involved in the regulation of GFP expression, instead of HCMV
replication. Meanwhile, knockdown of other candidates had
limited impact on primary replication, but virus production
was substantially inhibited. These factors would represent false
negative candidates in the conventional single-step screens. This
analysis highlighted the advantages of the two-step screening
approach in identifying host factors involved in both early
(such as entry and early gene expression) and late (such as late
gene expression and virion assembly/egress) stages of the virus
life cycle. The screen successfully identified valosin containing
protein, VCP, as an essential host factor for HCMV primary
replication (Lin et al., 2017). VCP is a member of the hexameric
AAA ATPase family and it plays a role in ubiquitin mediated
signaling through remodeling target proteins, which are often
degraded by proteasomes. It was found that VCP is involved
in regulating expression of two viral major immediate-early
genes, IE1 and IE2, and VCP knockdown resulted in loss of
IE2 expression and subsequent loss of early and late gene
expression. VCP was also shown to colocalised with the viral
replication compartments in the nucleus and a small molecule
inhibitor of VCP, NMS-873, was shown to be a potent HCMV
antiviral. The same screen also identified novel host factors
involved in virus assembly and egress, including ERC1, RAB4B,
COPA, and COPB2 (McCormick et al., 2018). Knockdown of
these candidates resulted in little or no reduction in primary
replication but significantly reduced virus production. Further
characterization studies showed distinct functions of these four
host genes in the regulation of virus gene expression, DNA
amplification, assembly and egress.
More recently we reported a high-throughput siRNA screen
using a library targeting 6,881 host genes that are considered to be
druggable and have high therapeutic potential (Lee et al., 2019).
Using normal human dermal fibroblast cells (NHDF, similar to
HFFs) and TB40/E-GFP, the screen identified 47 proviral and 68
antiviral factors involved in a broad range of cellular functions,
such as transcription regulation by the mediator complex and
proteasomal degradation. Asparagine synthetase (ASNS) was
shown to be a previously unreported proviral factor for HCMV. It
was found that knockdown of ASNS inhibited HCMV replication
at an early stage and further analyses by western blotting showed
that IE2 expression was inhibited in ASNS depleted cells. There
are a number of studies demonstrating that amino acids function
more than just in protein biosynthesis; instead, they are involved
in a number of cellular pathways including cell cycle, apoptosis,
and protein translation (Gong and Basilico, 1990; Kimball and
Jefferson, 2006; Jewell et al., 2013; Meijer et al., 2015). The main
function of ASNS is to produce the non-essential amino acid
asparagine via glutamine and aspartate in an ATP-dependent
manner. Asparagine has been shown to affect the cell cycle as
a depletion of intracellular asparagine levels induces cell cycle
arrest at the G1 phase (Gong and Basilico, 1990). However, since
HCMV induces cell cycle arrest at the G1/S phase, the induction
of cell cycle arrest by asparagine depletion does not explain an
early inhibition of virus replication. Asparagine has also been
shown to regulate uptake of amino acids in cancer cells and
indirectly, as an amino acid exchange factor, regulates the mTOR
pathway which controls protein synthesis (Krall et al., 2016).
Previously, a series of studies showed that HCMV maintains
mTOR activation during deprivation of essential amino acids
through the binding and antagonizing of a major mTOR
suppressor, tuberous sclerosis subunit complex 2 (TSC2), by the
viral UL38 protein (Moorman et al., 2008; Terhune et al., 2010;
Clippinger et al., 2011; Rodriguez-Sanchez et al., 2019). As with
essential amino acid deprivation,mTOR activity, measured by the
phosphorylation of S6 kinase, was also maintained by the virus
following ASNS knockdown. Furthermore, knockdown of ASNS
did not affect virus replication of another human herpesvirus,
herpes simplex virus-1 (HSV-1), nor influenza A virus, suggesting
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ASNS depleted cells are still capable of continuing protein
synthesis and supporting virus replication. These data suggest
that there may be an unknown pathway regulated by intracellular
asparagine levels impacting HCMV replication. To demonstrate
that the effect of ASNS knockdown is due to decreased asparagine
levels, we demonstrated that virus replication is fully rescued
by adding exogenous asparagine at the time of infection in
ASNS-depleted cells. Remarkably, upon ASNS depletion, virus
replication can be completely rescued by supplying exogenous
asparagine up to 7 days post-infection. This suggests that in ASNS
depleted cells, HCMV is able to enter the cell and expresses IE1
but not IE2; thus, the virus remains dormant within the cell but
retains the capacity for full replication days after initial infection
and requires only asparagine to resume its replication.
There are studies in cancer cells showing the requirement of
asparagine for cellular adaptation during glutamine starvation
and for nucleotide biosynthesis (Zhang et al., 2014; Zhu et al.,
2017). Furthermore, asparaginase, an enzyme that catalyzes
asparagine into aspartate and ammonia, has been used to treat
cancers including acute lymphoblastic leukemia, acute myeloid
leukemia and non-Hodgkin’s lymphoma (Hettmer et al., 2015; Bu
et al., 2016; Egler et al., 2016). However, asparaginase resistance
is reported in some cases of cancers and the use of ASNS
inhibitors has been proposed and is currently in the development
process (Gutierrez et al., 2006). Therefore, there is a possibility to
repurpose anti-cancer drugs to treat HCMV based on the similar
dependency upon asparagine between cancers and HCMV, or
perhaps a simple dietary restriction in patients with high risk of
HCMV infection may prevent the spread of the virus. The ability
to “resume” virus replication by adding exogenous asparagine
in ASNS-depleted cells also suggests the potential impact of
asparagine levels and ASNS expression on the establishment and
maintenance of HCMV latency. At this stage, it is unclear why
HCMV requires asparagine to replicate efficiently whilst other
herpesviruses such as HSV-1, does not.
Another way to measure virus infection in a high-throughput
siRNA screen is to quantify levels of key viral transcripts
by RNA-seq or reverse transcription-quantitative polymerase
chain reaction (RT-qPCR) (Song et al., 2019). Recently, a high-
throughput siRNA screen was reported which examined the
role of cellular RNA-processing factors in immune regulation
during HCMV lytic infection. Targeting 687 genes involved in
cellular RNA processing, including RNA-binding proteins and
ribonucleases using pooled siRNAs (4 siRNAs per gene), HFF
cells were infected with HCMV low-passage strain Toledo and
infection efficiency was quantified by measuring the mRNA
levels of IE1 (immediate-early), UL44 (early), and UL99 (late)
genes at 48 HPI (Song et al., 2019). Knockdown of 36 genes
showed at least 3-fold decrease in mRNA levels of viral
late gene UL99 expression. The authors followed up on one
of the candidates, an RNA-binding protein Roquin encoded
by the RC3H1 gene, and showed that the expression of
Roquin is induced by HCMV and is required for efficient
productive infection. Roquin plays important roles in both the
innate and adaptive immune systems and promotes mRNA
decay of transcripts with roles in immunity (Athanasopoulos
et al., 2016). RNA-seq analysis performed in HCMV-infected
and mock-infected Roquin depleted cells revealed increased
production of pro-inflammatory cytokines such as interleukin-
6 (IL-6) and IL-1B. However, the increased production of
pro-inflammatory cytokines, chemokines, interferons (IFN) and
interferon-stimulated genes (ISGs) was more drastic in infected
cells, with cytokine levels being induced over 200-fold at 72 HPI.
IFN and ISGs showed robust induction at 24 HPI in Roquin
depleted cells. Cross-linking immunoprecipitation (CLIP)-seq
analysis was performed to identify mRNA sequences targeted
by Roquin during HCMV infection and found an enrichment
of previously known Roquin targets such as pro-inflammatory
cytokine IL-6 and chemokine CXCL2, as well as novel
targets including dickkopf WNT signaling pathway inhibitor 1
(DKK1) and interferon regulatory factor 2 binding protein like
(IRF2BPL). The mRNA targets identified in CLIP-seq analysis
were also found enriched in Roquin depleted cells, suggesting
that Roquin selectively targets these genes for downregulation
during HCMV infection. Finally, in order to determine the
specific Roquin targets involved in HCMV gene expression,
109 genes that showed increased expression upon Roquin
depletion were selected for siRNA knockdown, along with
Roquin depletion and infection monitored by quantifying the
mRNA level of HCMV late gene UL146. Upon knockdown in
HCMV-infected Roquin depleted cells, ANKRD52, CDK6, CFL2,
and IRF1 showed a >50% rescue of UL146 gene expression. The
authors suggested that Roquin may downregulate the expression
of ANKRD52 to inhibit cellular miRNA-dependent regulation
that may be involved in innate antiviral responses. Furthermore,
suppression of CDK6 and CFL2 via Roquin can establish the
cellular environment by controlling cell cycle and cytoskeleton,
respectively. Since IRF1 is a well-characterized transcriptional
activator of various cytokines, its role as a target by Roquin
during HCMV replication was further studied. It was concluded
that Roquin-mediated down-regulation of IRF1 is important for
HCMV replication by mediating cytokine levels.
shRNA Studies of HCMV
In addition to siRNA screens with individual gene knockdown
in microwell plate formats, large-scale pooled shRNA expression
lentiviral vector libraries provide another application for
identification of host-virus interactions. shRNAs are about 80
nucleotides in length with a stem-loop structure similar to
pre-miRNA (Fennell et al., 2014). They require processing
by the Dicer protein before being incorporated into RISC.
Unlike siRNAs which are usually transfected into cells as
duplex RNAs, shRNAs are usually engineered into lentivirus
vectors and integrated into genomic DNA for longer and more
stable expression.
A high-throughput shRNA screen was employed to identify
host factors involved in HCMV US11-mediated HLA class I
degradation via the endoplasmic reticulum associated protein
degradation (ERAD) pathway. A high-coverage shRNA library
consisting of around 55,000 sequences (around 30 individual
shRNAs per gene) that target all known human protein-
encoding genes was generated (van de Weijer et al., 2014).
Each shRNA lentivirus vector expresses mCherry. A U937
monocytic cell line co-expressing HCMV US11 and a chimeric
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HLA-A2 molecules with N-terminally tagged eGFP and Myc-
epitope were used. Using the chimeric HLA-A2 molecules as
an indication of US11-mediated degradation, the level of HLA
class I molecule expression can be monitored by measuring
GFP signal on the cell surface by flow cytometry or using a
Myc specific antibody. Prior to shRNA transduction, it was
confirmed that HCMV US11 expression significantly reduces
the GFP expression from the chimeric HLA-A2 molecules.
Following shRNA transduction, cells were sorted via GFP
signal into GFP-bright and GFP-dim populations, and the GFP-
bright population is further sorted for purity through selecting
mCherry positive cells (cells transducedwith an shRNA lentivirus
vector) and GFP-bright cells. Around 2.8 million mCherry
positive, GFP-bright cells per screen were selected for deep
sequencing, along with 115 million mCherry positive, GFP-
dim cells as control. GFP-bright populations are considered to
have disrupted US11-mediated HLA class I downregulation. Two
independent screens were performed and overlapping genes in
the top 100 of two screens include coatomer subunits (e.g.,
COPA and COPB2) and proteasome subunits (e.g., PSMD1
and PSMC2). VCP was also identified as a clear hit, and this
gene was identified in our medium-throughput siRNA screen
(Lin et al., 2017). Several proteins involved in the ubiquitin
pathway were identified in the GFP-bright populations but did
not meet the strict cut-off requirements, including ubiquitin
B, ubiquitin C, ubiquitin-activating enzyme E1 (UAE1) and
the E2-conjugating enzyme UBE2J2. The authors focused on
transmembrane protein 129 (TMEM129), and showed that
TMEM129 is a novel E3 ubiquitin ligase and is important
for HCMV US11-mediated HLA class I downregulation. The
authors also demonstrated the involvement of UBE2J2, an E2
ubiquitin-conjugating enzyme, in the US11-mediated HLA class
I downregulation, using shRNA and CRISPR/Cas9 techniques.
A few years later, the same research groups further explored
their study and performed a CRISPR/Cas9 screen to identify
E2 ubiquitin-conjugating enzymes that are involved in the
regulation of HCMVUS2-mediated HLA class I downregulation.
Thirty-six known human E2 enzymes were targeted, and 112
single guide RNAs (sgRNAs) were generated (van de Weijer
et al., 2017). The same U937 monocytic cell line expressing
an HLA-A2 molecule with an N-terminal eGFP tag was used
to detect HLA class I expression mediated by HCMV US2. A
similar screening strategy to the shRNA screen was employed,
and UBE2G2 and UBE2D3 were identified as essential factors for
US2-mediated HLA class I downregulation as sgRNAs targeting
these two proteins led to an increased expression of GFP-tagged
HLA-A2molecules. However, sgRNAs targeting UBE2J2 resulted
in further downregulation of HLA-A2 expression, suggesting
that UBE2J2 counteracts the downregulation of HLA class I by
US2 during HCMV infection. Interestingly, UBE2J2 was also
identified in the shRNA screen, but it showed opposite functions
for US11-mediated and US2-mediated HLA class I degradation.
Unfortunately, the explanation on this was not given in the latter
report; however, it is possible that UBE2J2 is involved in the
regulation of HLA class I degradation between two viral proteins
in an unknown mechanism.
CRISPR/Cas9 Studies in HCMV
Cell-based RNAi has been the primary system for high-
throughput gene perturbation, but some challenges and
limitations persist, including toxicity and off-target effects
(Mashalidis et al., 2013; Jadhav, 2014). siRNA off-target effects
are common and can occur when unintended transcripts are
silenced by siRNA through partial sequence complementarity
or when passenger strands of the siRNA are loaded into RISC
(Jackson and Linsley, 2010; Lam et al., 2015). siRNAs and/or
their delivery vehicles can also trigger an inflammatory response
through activation of Toll-like receptors (TLRs), causing an
indirect inhibition of virus replication. However, pooling of
multiple siRNAs to the same target transcript can help reduce
off-target silencing, due to competition among the siRNAs in the
pool (Kittler et al., 2007).
Unlike RNAi, CRISPR/Cas9 technology directly targets
DNA for complete gene knockout and has been adapted
in high-throughput screens as it overcomes some limitations
of RNAi screens, including incomplete suppression of target
genes and off-target effects (Pickar-Oliver and Gersbach, 2019).
CRISPR/Cas9 allows specific manipulation of genomes based on
the expression of modified Cas9 protein and single guide RNAs
(sgRNAs). In nature, CRISPR is a prokaryotic immune response
to invading DNAs such as bacteriophages and transposons.
Specialized endonucleases called Cas proteins use CRISPR RNA
(crRNA) to recognize and cleave target sequence. Depending on
the Cas proteins, DNA can be nicked on one strand or cleaved
on both strands. Cas9 protein was first found in Streptococcus
pyogenes and reprogrammed for genome editing in mammalian
cells (Pickar-Oliver and Gersbach, 2019). Containing two distinct
nuclease domains, RuvC and HNH, Cas9 typically cleaves each
strand with each nuclease domain, generating a DNA double-
strand break (DSB) which is repaired by either homology directed
repair (HDR) pathway or non-homologous end-joining (NHEJ)
pathway. NHEJ repair is more common because the efficiency
of HDR depends on the concentration of a homologous DNA
template at the time of repair, the length of the homology, and
the activity of the endogenous repair system (Lin et al., 2014;
Maruyama et al., 2015). Due to the error-prone nature of the
NHEJ repair pathway, mutations by insertion or deletion at the
target site are often introduced, subsequently causing potential
frameshift and downstream premature stop codons.
A human genome-wide CRISPR knockout (GeCKO) library
has been used in a screen to identify host factors required
for HCMV replication. The library targeted 19,050 human
genes with over 120,000 sgRNA sequences (Wu et al., 2018).
Two HCMV strains that only express viral trimer glycoprotein
complex (gH/gL/gO), AD169 with a frame-shift insertion in
UL131A and Merlin with a nonsense mutation in UL128, were
used to infect HFFs. The surviving cells following infection
were collected for sequence analysis of sgRNA enrichment,
and sgRNAs targeting platelet-derived growth factor receptor
alpha (PDGFRα) were enriched in cells infected with both
trimer-only viruses. It was shown that the immunoglobulin-like
domain 3 of PDGFRα, but not the kinase domain, is required
for HCMV entry via trimeric complex. However, PDGFRα
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TABLE 1 | Summary of high-throughput studies.





RNA-seq Batra et al. (2016) Affymetrix microarrays; poly-A
selected RNA-seq; TAIL-seq




Over 2,000 altered host
RNA splicing events in
infected HFFs and NPCs
Proteomics Weekes et al.
(2014)
TMT proteomics of 1,184
surface proteins and 7,491
cellular proteins
HFFFs (HFFs) Merlin HCMV protein
expression profile
Not specified
Jean Beltran et al.
(2016)
Subcellular fractionation,
TMT-based and label-free mass
spectrometry and confocal
microscopy
HFFs AD169-GFP GFP expression from
the virus
796 proteins downregulated
and 593 upregulated up to
96 HPI; 374 proteins
showed translocation upon
infection
Arend et al. (2017) Multiplexed kinase inhibitor
bead-mass spectrometry
(MIB-MS) quantitatively




















131 proteins were rescued
by MG132 and 28 proteins
by leupeptin within 24 h of
infection




HFFs AD169 Viral protein
expression profile of
IE1, pUL26 and pp65
52 peroxisome proteins
showed increased





An siRNA library, in a pool of 4




26 proviral and 25 antiviral
hits
Lin et al. (2017) An siRNA library, in a pool of 4
siRNAs, targeting 140
membrane trafficking genes and
20 other selected genes






An siRNA library, in a pool of 4
siRNAs, targeting 156 host
genes
NHDF (HFFs) TB40/E-GFP SV40 promoter driven
GFP expression from
the virus
11 proviral and 31 antiviral
hits from the virus
production screen
Lee et al. (2019) An siRNA library, in a pool of 4
siRNAs, targeting 6,881 host
genes with high therapeutic
potential
NHDF (HFFs) TB40/E-GFP SV40 promoter driven
GFP expression from
the virus
47 proviral and 68 antiviral
hits
Song et al. (2019) An siRNA library, in a pool of 4
siRNAs, targeting 687 host
genes involved in cellular RNA
processing
HFFs Toledo RT-qPCR of IE1,
UL44, UL99 at 48 HPI




van de Weijer et al.
(2014)
A high-coverage shRNA library
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Not specified; top 100
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CRISPR
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van de Weijer et al.
(2017)
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eGFP-HLA-A2
Wu et al. (2018) A human genome-wide GeCKO
library targeting 19,050 human











Not specified; top 10
enriched sgRNAs shown
(Continued)
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Xiaofei et al. (2019) A human genome-wide GeCKO
library targeting 19,050 human
genes with over 120,000
sgRNAs






sgRNAs, each with ≥20





RISC-IP using an AGO2 specific
antibody
NHDF (HFFs) AD169 and TR N/A 686 transcripts were




Kim et al. (2015) AGO-CLIP-seq using a
pan-AGO antibody
HFFs TowneLONG N/A 3,909 HTVs** from data
collected at 24, 48, and 72
HPI
+TMT, tandem mass tag; RISC-IP, RNA-induced silencing complex immunoprecipitation.
*NPCs, neural progenitor cells; HFFs, human foreskin fibroblasts; ECs, endothelial cells; HFFFs, human fetal foreskin fibroblast; HFFF-TERTs, HFFF immortalized with human telomerase;
NHDF, normal human dermal fibroblast; HEL, human embryonic lung fibroblast.
**HTVs, human targets of the viral miRNAs.
N/A, not applicable.
knockout fibroblast cells remain susceptible to HCMV that
propagates in epithelial cells expressing pentameric complex
(gH/gL/pUL128-pUL130-pUL131A).
A recent CRISPR/Cas9 screen identified an olfactory receptor
family member, OR14I1, as an essential receptor for attachment,
entry and infection of epithelial cells by pentameric complex
expressing HCMV (Xiaofei et al., 2019). Using the same
human GeCKO library (19,050 human genes, 6 sgRNAs per
gene), two parallel screens were performed in either adult
retinal pigment epithelial cell line 19 (ARPE-19) infected with
epithelial-tropic TB40/E (expressing both trimeric gH/gL/gO
and petameric gH/gL/pUL128-pUL130-pUL131A complexes) or
human embryonic lung (HEL) fibroblast cells infected with
fibroblast-tropic AD169 (expressing only trimeric gH/gL/gO
complexes). Following CRISPR knockout, cells were repeatedly
exposed to HCMV infection over 3 months at an MOI of
5. When 95% of respective cells had died, the surviving
cells were expanded and subjected to a second round of
infection. The surviving cells with sgRNA-induced resistance
to HCMV were subjected to next-generation sequencing to
identify enriched sgRNAs. sgRNAs against either OR14I1 or
PDGFRαwere found enriched in pentamaric complex expressing
TB40/E infected cells. However, only sgRNAs against PDGFRα
were enriched in trimeric complex expressing AD169 infected
fibroblast cells, suggesting OR14I1 is not required for entry via
trimeric complexes. OR14I1 is a G protein coupled receptor
belonging to the olfactory receptor family, which is traditionally
thought of as chemosensors for olfaction. However, it has been
demonstrated previously that infectious agents exploit olfaction-
related receptors for transmission and infection, such as murine
CMV (MCMV) (Farrell et al., 2016). Therefore, it was intriguing
that HCMV also requires an olfactory receptor for entry. Using
a membrane flotation assay and immunoblots, it was shown
that TB40/E, which expresses both trimeric and pentameric
complexes, requires both OR14I1 and PDGFRα for optimal
binding to epithelial cells. OR14I1 is predicted to have 4 peptide
regions exposed on the cell surface and the first region, amino
acid 1–26, was found to have the capability to interact with the
pentameric complex, thereby limiting the binding and replication
of TB40/E in epithelial cells. The authors also demonstrated
that OR14I1 is required for the activation of adenylate cyclase
(AC)/protein kinase A signaling pathway and the combination
of OR14I1 binding and AC activity is required for TB40/E entry.
CRISPR/Cas9 offers a complete gene knockout by introducing
mutations in target sites, instead of silencing gene expression by
inducing mRNA degradation or disrupting translation. Loss-of-
function CRISPR/Cas9 screens can be performed using sgRNAs
against exons, non-coding regions or transcription factor motifs
(Pickar-Oliver and Gersbach, 2019). There are several factors
that can affect the efficacy of the CRISPR/Cas9 screen, including
off-target cutting, incidence and efficiency of HDR vs. NHEJ,
and Cas9 activity (Lino et al., 2018). However, one of the major
challenges of the two screens discussed in this review is bias
toward the enrichment of sgRNAs targeting surface receptors for
virus entry. Although the importance of PDGFRα for trimeric
complex expressing HCMV entry was successfully validated and
OR14I1 as a novel receptor for pentameric complex expressing
HCMV was identified, the enrichment of sgRNAs against other
cellular factors that may be involved in viral gene expression or
other processes is less substantial. There are potential approaches
to circumvent the bias of currently published CRISPR. For
example, instead of using pooled lentiviral vectors and survival
assays, high-throughput microplate systems, similar to siRNA
screens, with each well containing sgRNAs targeting the same
gene can be used. Furthermore, fluorescent activated cell sorting
(FACS) can also be adapted to measure virus infection and sort
cells based on the level of virus replication prior to sequencing
for sgRNA enrichment. There is also a future revenue in single
cell sequencing following a CRISPR screen as it helps to dissect
cellular differences at higher resolution and understanding how
individual cells respond to infection. Adaptation of other high-
throughput techniques such as liquid handling automation for
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 10 June 2020 | Volume 10 | Article 280
Lee and Grey Systems Virology and Human Cytomegalovirus
liquid dispensation and collection in microplates and high-
content microscopy and improvement on design of sgRNA
libraries may lead to a new generation of CRISPR/Cas9 screens
with higher rates of hit identification.
miRNA Studies in HCMV
A more indirect, but potentially powerful approach for the
identification of novel host-virus interactions is through miRNA
target discovery. Herpesviruses express their own viral miRNAs
that can target both viral and cellular transcripts. Viruses also
modulate the expression of cellular miRNAs, thereby indirectly
affecting host gene expression. By identifying targets of viral
miRNAs, novel host factors important for virus replication can
be discovered; in essence, using the virus to indicating which host
genes are important for its replication cycle.
miRNAs are initially transcribed as long primary miRNA
(pri-miRNA) with one or more sequences that can hybridize
and form hairpin structures (Fennell et al., 2014). The pri-
miRNA is processed by RNase Drosha/Pasha in the nucleus to
produce pre-miRNAs which have individual stem-loop hairpin
structures. Pre-miRNAs are exported to the cytoplasmwhere they
are processed by the Dicer protein to form short double-stranded
siRNA-like miRNA duplexes, which are 19–25 nucleotide long
(Tomari and Zamore, 2005; Lam et al., 2015). A single-stranded
mature miRNA is then incorporated into the RNA-induced
silencing complex (RISC) which uses the miRNA sequence as
a guide to recognize complementary mRNA transcripts and
cleaves the mRNA via Argonaute protein which is within
RISC. miRNAs modulate gene expression primarily through
targeting the 3′ untranslated region (3′UTR) of genes, and
FIGURE 1 | Host factors identified in high-throughput studies and their role in HCMV infection. The life cycle of HCMV is summarized in the figure and candidates
identified in each type of high-throughput studies were shown in their approximate functional location. Candidates identified in each type of high-throughput studies
are in: red (RNA-seq), blue (proteomics), green (siRNA), purple (shRNA), brown (CRISPR), pink (miRNA).
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often have multiple targets through partial complementarity
(Fennell et al., 2014).
Previously, our lab performed a systematic RISC
immunoprecipitation (RISC-IP) analysis to identify host factors
targeted by HCMV-encoded miRNAs (Pavelin et al., 2013).
By pulling down RISC using an argonaute 2 (AGO2) specific
antibody and analyzing mRNA transcripts by microarray,
ATP6V0C, a vacuolar ATPase complex involved in acidification
of endosomal compartments, was identified as a novel target
of viral mir-US25-1. Interestingly, further characterization
studies using siRNA against ATP6V0C showed that depletion
of ATP6V0C resulted in almost complete loss of infectious
virus production, suggesting that HCMV targets a crucial host
factor required for productive virus replication. ATP6V0C
was also found to be required for the formation of virion
assembly compartment (VAC) during HCMV infection (Pavelin
et al., 2017). Currently, it is still not completely understood
why HCMV targets ATP6V0C. We suggested that it may be
related to the establishment of latency or immune evasion
as endosomal acidification is required for efficient MHC
class II antigen presentation, but a mechanism remains to
be established.
Subsequently, argonaute-crosslinking and immuno
precipitation followed by high-throughput screening (AGO-
CLIP-seq, also known as Ago HITS-CLIP) was performed in
HCMV strain Townelong infected HFFs in order to identify
miRNA-target interaction sites (Kim et al., 2015). Compared
to the RISC-IP analysis, the AGO-CLIP-seq involves UV-
crosslinking of RNA with argonaute (AGO) proteins and
sequencing of mRNAs and small RNAs. Furthermore, a pan-
AGO-specific monoclonal antibody was used instead of an
AGO2-specific antibody; thus, the results will reveal miRNAs
associated with all AGO proteins rather than specific interactions
with AGO2. In mammals, there are four AGO proteins but only
AGO2 is catalytically active and can degrade target transcripts
(Meister, 2013). The AGO-CLIP-seq identified 3,909 human
targets of the viral miRNAs (HTVs) from data collected at 24,
48, and 72 HPI, and these target gene groups contain the peak
clusters with enrichment higher in infected samples than in
uninfected samples. Thirty high-confidence candidates were
selected for validation by quantitative real-time PCR (qRT-PCR)
to examine the fold reduction in mRNA expression following
transfection with targeting viral miRNAs into HFFs. At 48 h post-
transfection, 26 of 30 were significantly downregulated. mRNA
levels of most of these targets were recovered or noticeably
higher when infected with miRNA-mutant viruses. The authors
focused on two pathways that are targeted by viral miRNAs: cell
cycle/apoptosis/autophagy and interferon JAK/STAT signaling,
and validated their results using viral miRNA mimics and
luciferase reporter assays for the 3′UTR of target mRNAs.
Finally, the targetomes of human miRNAs were also investigated
using the same dataset and it was found that increased expression
of human miRNAs usually leads to decreased overall mRNA
expression of targets; however, decreased expression of human
miRNAs does not increase the overall mRNA expression.
These experiments help dissect complex miRNA-mediated host
manipulation during HCMV lytic infection.
CONCLUDING REMARKS AND FUTURE
DIRECTIONS
Systems virology, involving high-throughput molecular profiling
and bioinformatics, has highlighted the complexity of host-
virus interactions and contributed to our understanding of how
HCMV works, novel cellular functions and potential new drug
targets (Law et al., 2013). The screens discussed in this review are
summarized in Table 1. The validated candidates in each screen
are illustrated in Figure 1, with each color showing the type of
screens the candidate was identified in.
With advances in sequencing, mass spectrometry and genome
editing, high-throughput studies become more efficient and
accurate in the identification of host-virus interactions. Despite
the discovery of novel host factors important for virus replication,
the precise functions and roles of these factors remain to be fully
elucidated. The potential of these factors as antiviral targets will
also require extensive examinations in vivo prior to proceeding
to clinical trials. The development of host-oriented antivirals will
have lower rates of the emergence of drug-resistant virus, thereby
providing a better option for therapeutics. However, drug toxicity
in the host is a major challenge most novel antivirals need to
overcome because some host factors are required for normal
cellular functions.
Integrating the various high throughput approaches, from
RNA-seq to proteomics to phenotypic screens, represents an
attractive future goal of systems approaches in HCMV research
as well as systems research in general. With improving pathway
analysis, integrated systems approaches may lead to major
advances in our understanding of basic virus biology, cell biology
and the discovery of novel antiviral therapies.
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